2013 American Transplant Congress
Donation after Circulatory-Death in the UK
Background: The number of deceased donors in the UK has increased from 809 in 2007-8 to 1088 in 2011-2. This increase can be ascribed, predominantly,…2013 American Transplant Congress
Rat Liver Allo-Graft Rejection Promotes Anti-Cancer Immunity: A Model of Transplantation for Hepatocellular Carcinoma
Background: Liver transplantation for hepatocellular carcinoma (HCC) results in a specific condition where the immune response is directed both against allogeneic and cancer antigens. This…2013 American Transplant Congress
Morphometric Age as a Predictor of Post Liver Transplant Survival
General Surgery, Division of Transplant Surgery, University of Michigan, Ann Arbor
INTRODUCTION: Better measures of pre-operative risk stratification are needed in liver transplantation. A cornerstone of a surgeon’s clinical assessment is best described as the “eyeball…2013 American Transplant Congress
Natural Regulatory T-Cells Impair the Donor-Specific Cytotoxic T-Cell Response Long after Transplantation
Internal Medicine - Transplantation, Erasmus MC, Rotterdam, Netherlands
Introduction: CD4+CD25highCD127- are potent regulators of cytokine production and proliferation of alloreactive T-cells. Although, cytotoxic T-cells are the effector cells that destroy the allograft. The…2013 American Transplant Congress
Cigarette Smoking in Living Kidney Donors and Graft Survival
General Surgery, Division of Transplant Surgery, University of Michigan, Ann Arbor, MI
Background: The deleterious effects of cigarette smoking contribute to a number of significant health-related problems but the effect of donor smoking history on kidney graft…2013 American Transplant Congress
Risk of Transmission of Cancer from Solid Organ Donors in the U.S
National Cancer Institute, Rockville, MD
Background: Transmission (TX) of cancer is a rare but life-threatening complication of transplantation. Most cancers preclude donation, but some may be missed if an accurate…2013 American Transplant Congress
Efficacy and Safety of Calcineurin Inhibitor Withdrawal in Living Donor Kidney Transplantation with Older Donors
Background: Living donor kidney transplantation recipients with older donors often have lower GFR than whom with young donors after transplantation. Calcineurin inhibitor (CNI) may cause…2013 American Transplant Congress
Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys
Background: Kidney transplant recipients treated with belatacept-based immunosuppression in the BENEFIT-EXT study had comparable patient and graft survival and better renal function vs a cyclosporine-based…2013 American Transplant Congress
Triple Non-Steroidal Maintenance Therapy in a Cohort of Kidney Transplanted Children
Paediatric Nephrology Department, Hospital Vall d'Hebron, Barcelona, Spain
BACKGROUND:Calcineuric inhibitors (CNI) avoidance or dose reduction has been proposed in pediatric kidney transplant (KTx) recipients with nephrotoxicity or neurologic side effects. Combination of CNI,…2013 American Transplant Congress
Medication Non-Adherence after Kidney Transplantation: A Qualitative Study Using Depth Interviews of Adherent and Non-Adherent Patients
Background: Non-adherence to immunosuppressive medications is an important cause of allograft loss after kidney transplant. To examine factors influencing medication adherence in adult kidney transplant…
- « Previous Page
- 1
- …
- 133
- 134
- 135
- 136
- 137
- …
- 178
- Next Page »